Hiv

SAN FRANCISCO — Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, baseline suppressive therapies among adults with HIV.

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.

SAN FRANCISCO — Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic Infections.

SAN FRANCISCO — Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that could transform the landscape of HIV prevention.

SAN FRANCISCO — Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP adherence among pregnant and postpartum women, researchers found.

SAN FRANCISCO — During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV survivor, addressed conference attendees and discussed her experiences of living with HIV.

SAN FRANCISCO — HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled from decades of studies, researchers found.

Home-based HIV counseling and relationship building improved HIV testing, diagnoses and viral suppression among pregnant couples during a trial in Kenya, researchers reported.

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow disease, physicians reported Monday.

Healio will be providing live coverage of the Conference on Retroviruses and Opportunistic Infections, which runs from March 9-12 in San Francisco.